Pre- and postoperative risk factors for hospital complications upon atypically localized left atrial myxomas

Introduction: Cardiac myxoma is the most common of the benign heart tumor. In the left atrium, it is typically located in the interatrial septum in the area of the fossa ovale; any other its localization is considered atypical. The consequences of surgical treatment of typical myxomas have been sufficiently examined; however, there are no data on treatment of atypically localized left atrium myxomas. Objective: The study is aimed to analyzing the results of surgical intervention upon atypically localized left atrium myxomas and assessing of pre- and postoperative risk factors for adverse hospital events as well as embolic complications. Methods: A retrospective review of the results upon surgical treatment of atypically localized left atrial myxomas (n = 52) through the period from 2008 to 2022 was performed.Results: Non-lethal in-hospital complications are revealed in 15 patients (29%). In-hospital mortality is 6% (n = 3). A comparative analysis of transthoracic echocardiography data, collected before surgical intervention and at the time of hospital discharge, demonstrated a decrease in the left ventricular end diastolic volume and in the left atrial dimensions (P < 0.001). Risk factors for non-lethal in-hospital complications are related to the chronic heart failure NYHA 3 (P < 0.01) and EuroSCORE II (P = 0.03). Risk factors for hospital mortality are associated with advanced age (P = 0.03) and EuroSCORE II (P = 0.03). Preoperative embolic complications are attributed to localization of myxoma on the posterior wall of the left atrium (P = 0.02), villous myxoma (P < 0.001), myxoma prolapse into the left ventricle cavity (P = 0.05).Conclusion: The presented results of surgical treatment of atypically localized left atrium myxomas are comparable to the data of the world literature, including hospital mortality rates (6%). Preoperative risk factors for non-lethal complications are related to chronic heart failure NYHA 3 and EuroSCORE II; for lethal complications they are associated with the age of patients over 65 years and EuroSCORE II. No significant effect of postoperative risk factors on lethal and non-lethal hospital complications was revealed. Received 3 May 2023. Revised 16 April 2024. Accepted 4 June 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: T.A. Simonyan, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanData collection and analysis: T.A. Simonyan, I.M. Tsiskaridze, I.Yu. Farulova, L.V. Spirin, M.S. IbragimovStatistical analysis: T.A. Simonyan, I.M. TsiskaridzeDrafting the article: T.A. Simonyan, I.M. TsiskaridzeCritical revision of the article: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanFinal approval of the version to be published: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. Kakhktsyan, I.Yu. Farulova, L.V. Spirin, M.S. Ibragimov

Authors

Publication Details

Journal
Patologiya krovoobrashcheniya i kardiokhirurgiya
Published
2024-08-29
DOI
https://doi.org/10.21688/1681-3472-2024-2-30-40
Citations
2
Primary Topic
Cardiac tumors and thrombi
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pre- and postoperative risk factors for hospital complications upon atypically localized left atrial myxomas

I.I. Scopin, М.С. Ибрагимов, T.A. Simonyan, P.V. Kakhktsyan et al.
2 citations
Patologiya krovoobrashcheniya i kardiokhirurgiya
Cardiac tumors and thrombi
0.80
article

Pre- and postoperative risk factors for hospital complications upon atypically localized left atrial myxomas

I.I. Scopin, М.С. Ибрагимов, T.A. Simonyan, P.V. Kakhktsyan, I. M. Tsiskaridze, I.Yu. Farulova, L.A. Bockeriа, L.V. Spirin
article en
2 citations

Abstract

Introduction: Cardiac myxoma is the most common of the benign heart tumor. In the left atrium, it is typically located in the interatrial septum in the area of the fossa ovale; any other its localization is considered atypical. The consequences of surgical treatment of typical myxomas have been sufficiently examined; however, there are no data on treatment of atypically localized left atrium myxomas. Objective: The study is aimed to analyzing the results of surgical intervention upon atypically localized left atrium myxomas and assessing of pre- and postoperative risk factors for adverse hospital events as well as embolic complications. Methods: A retrospective review of the results upon surgical treatment of atypically localized left atrial myxomas (n = 52) through the period from 2008 to 2022 was performed.Results: Non-lethal in-hospital complications are revealed in 15 patients (29%). In-hospital mortality is 6% (n = 3). A comparative analysis of transthoracic echocardiography data, collected before surgical intervention and at the time of hospital discharge, demonstrated a decrease in the left ventricular end diastolic volume and in the left atrial dimensions (P < 0.001). Risk factors for non-lethal in-hospital complications are related to the chronic heart failure NYHA 3 (P < 0.01) and EuroSCORE II (P = 0.03). Risk factors for hospital mortality are associated with advanced age (P = 0.03) and EuroSCORE II (P = 0.03). Preoperative embolic complications are attributed to localization of myxoma on the posterior wall of the left atrium (P = 0.02), villous myxoma (P < 0.001), myxoma prolapse into the left ventricle cavity (P = 0.05).Conclusion: The presented results of surgical treatment of atypically localized left atrium myxomas are comparable to the data of the world literature, including hospital mortality rates (6%). Preoperative risk factors for non-lethal complications are related to chronic heart failure NYHA 3 and EuroSCORE II; for lethal complications they are associated with the age of patients over 65 years and EuroSCORE II. No significant effect of postoperative risk factors on lethal and non-lethal hospital complications was revealed. Received 3 May 2023. Revised 16 April 2024. Accepted 4 June 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: T.A. Simonyan, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanData collection and analysis: T.A. Simonyan, I.M. Tsiskaridze, I.Yu. Farulova, L.V. Spirin, M.S. IbragimovStatistical analysis: T.A. Simonyan, I.M. TsiskaridzeDrafting the article: T.A. Simonyan, I.M. TsiskaridzeCritical revision of the article: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanFinal approval of the version to be published: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. Kakhktsyan, I.Yu. Farulova, L.V. Spirin, M.S. Ibragimov

Patologiya krovoobrashcheniya i kardiokhirurgiyaVol. 28(2)
Good health and well-being
Openalex Percentile: Top 24%
Cardiac tumors and thrombi
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.